Skip to main content
Top
Published in: Archives of Virology 8/2017

01-08-2017 | Original Article

Recombinant foot-and-mouth disease virus (FMDV) non-structural protein 3A fused to enhanced green fluorescent protein (EGFP) as a candidate probe to identify FMDV-infected cattle in serosurveys

Authors: Cecilia M. Lotufo, Ingrid E. Bergmann, Nora M. Mattion, Maximiliano Wilda, Pablo R. Grigera

Published in: Archives of Virology | Issue 8/2017

Login to get access

Abstract

Recombinant protein 3A-EGFP, a fusion construct between foot-and-mouth disease virus (FMDV) non-structural protein 3A and the enhanced green fluorescent protein (EGFP) was expressed in BL21-DE3 cells. The identity of the partially purified protein 3A-EGFP was confirmed by its reactivity with sera from cattle infected with FMDV and with a monoclonal antibody specific for FMDV-3ABC (MAb3H7) in Western blot assays. No reactivity was observed with sera from uninfected vaccinated animals. The performance of 3A-EGFP as an antigen in an indirect enzyme-linked immunosorbent assay (ELISA) was assessed and compared with that of a previously developed and validated capture ELISA that uses a 3ABC recombinant antigen (3ABC ELISA) and has been widely applied for serological surveys in Argentina. Parallel analysis of strongly and weakly positive reference sera from infected animals and 329 serum samples from uninfected vaccinated cattle showed that the 3A-EGFP antigen unequivocally identifies sera from FMDV-infected cattle with similar performance to its 3ABC counterpart. The 3A-EGFP ELISA is simpler and faster to perform than the 3ABC ELISA, since it does not require a capture step with a specific antibody. Moreover, the expression and storage of the recombinant 3A-EGFP is simplified by the absence of residual autoproteolytic activity associated to the 3C sequence. We conclude that the 3A-EGFP ELISA constitutes a promising screening method in serosurveys to determine whether or not animals are infected with FMDV.
Literature
1.
go back to reference OIE Terrestrial Animal Health Code Terrestrial Code, 25th edn, 2016, ISBN of volume I: 978-92-95108-01-1) OIE Terrestrial Animal Health Code Terrestrial Code, 25th edn, 2016, ISBN of volume I: 978-92-95108-01-1)
2.
go back to reference Doel TR, Williams L, Barnett PV (1994) Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 1994(12):592–600CrossRef Doel TR, Williams L, Barnett PV (1994) Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. Vaccine 1994(12):592–600CrossRef
4.
go back to reference Ma Li-na, Zhang Jie, Chen Hao-tai, Zhou Jian-hua, Ding Yao-zhong, Liu Yong-sheng (2011) An overview on ELISA techniques for FMD. Virol J 1–8:419CrossRef Ma Li-na, Zhang Jie, Chen Hao-tai, Zhou Jian-hua, Ding Yao-zhong, Liu Yong-sheng (2011) An overview on ELISA techniques for FMD. Virol J 1–8:419CrossRef
5.
go back to reference Neitzert E, Beck E, Auge de Mello P, Gomes Y, Bergmann I (1991) Expression of the aphtovirus RNA polymerase gene in E. coli and its use together with other bioengineered non-structural antigens in detection of late persistent infections. Virology 184:799–804CrossRefPubMed Neitzert E, Beck E, Auge de Mello P, Gomes Y, Bergmann I (1991) Expression of the aphtovirus RNA polymerase gene in E. coli and its use together with other bioengineered non-structural antigens in detection of late persistent infections. Virology 184:799–804CrossRefPubMed
6.
go back to reference Rodríguez A, Dopazo J, Saiz JC, Sobrino F (1994) Immunogenicity of non-structural proteins of foot-and-mouth disease virus differences between infected and vaccinated swine. Arch Virol 136:123–131CrossRefPubMed Rodríguez A, Dopazo J, Saiz JC, Sobrino F (1994) Immunogenicity of non-structural proteins of foot-and-mouth disease virus differences between infected and vaccinated swine. Arch Virol 136:123–131CrossRefPubMed
7.
go back to reference Bergmann I, Malirat V, Neitzert E, Beck E, Panizzutti N, Sánchez C et al (2000) Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme linked immunoelectrotransfer blot assay. Arch Virol 145:473–489CrossRefPubMed Bergmann I, Malirat V, Neitzert E, Beck E, Panizzutti N, Sánchez C et al (2000) Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme linked immunoelectrotransfer blot assay. Arch Virol 145:473–489CrossRefPubMed
8.
go back to reference Robiolo B, Seki Cristina, Fondevilla Norberto, Grigera Pablo, Scodeller Eduardo, Periolo Osvaldo, La Torre Jose, Mattion Nora (2006) Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Vaccine 24:997–1008CrossRefPubMed Robiolo B, Seki Cristina, Fondevilla Norberto, Grigera Pablo, Scodeller Eduardo, Periolo Osvaldo, La Torre Jose, Mattion Nora (2006) Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests. Vaccine 24:997–1008CrossRefPubMed
9.
go back to reference Bergmann IE, Aug´e de Mello P, Neitzert E, Beck E, Gomes I (1993) Diagnosis of persistent aphtovirus infection and its differentiation from vaccination response by use of enzyme linked immunoelectrotransfer blot analysis with bioengineered non-structural viral antigens. Am J Vet Res 1989(54):825–831 Bergmann IE, Aug´e de Mello P, Neitzert E, Beck E, Gomes I (1993) Diagnosis of persistent aphtovirus infection and its differentiation from vaccination response by use of enzyme linked immunoelectrotransfer blot analysis with bioengineered non-structural viral antigens. Am J Vet Res 1989(54):825–831
10.
go back to reference De Diego M, Brocchi E, Mackay D, De Simone F (1997) The non-structural polyprotein 3ABC of Foot-and-Mouth Disease Virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol 142:2021–2033CrossRefPubMed De Diego M, Brocchi E, Mackay D, De Simone F (1997) The non-structural polyprotein 3ABC of Foot-and-Mouth Disease Virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol 142:2021–2033CrossRefPubMed
11.
go back to reference Clavijo A, Zhou E, Hole K, Galic B, Kitching P (2004) Development and use of e biotinylated 3ABC recombinant protein in a solid-phase competitive ELISA for the detection of antibodies against foot-and-mouth disease virus. J Virol Methods 120:217–227CrossRefPubMed Clavijo A, Zhou E, Hole K, Galic B, Kitching P (2004) Development and use of e biotinylated 3ABC recombinant protein in a solid-phase competitive ELISA for the detection of antibodies against foot-and-mouth disease virus. J Virol Methods 120:217–227CrossRefPubMed
12.
go back to reference Capozzo AV, Burke DJ, Fox JW, Bergmann IE, La Torre JL, Grigera PR (2002) Expression of foot -and-mouth disease virus non-structural polypeptide 3ABC induces histone H3 cleavage in BHK21 cells. Virus Res 90:91–99CrossRefPubMed Capozzo AV, Burke DJ, Fox JW, Bergmann IE, La Torre JL, Grigera PR (2002) Expression of foot -and-mouth disease virus non-structural polypeptide 3ABC induces histone H3 cleavage in BHK21 cells. Virus Res 90:91–99CrossRefPubMed
13.
go back to reference Mackay D, Forstyth MA, Davies PR, Berlinzani A, Beilsham GJ, Flint M (1998) Differentiating infection from vaccination in FMD using a panel of recombinant non-structural proteins in ELISA. Vaccine 5:446–459CrossRef Mackay D, Forstyth MA, Davies PR, Berlinzani A, Beilsham GJ, Flint M (1998) Differentiating infection from vaccination in FMD using a panel of recombinant non-structural proteins in ELISA. Vaccine 5:446–459CrossRef
14.
go back to reference Jaworski P, Compaired D, Trotta M, Perez M, Trono K, Fondevila N (2011) Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus. J Virol Methods 178:191–200CrossRefPubMed Jaworski P, Compaired D, Trotta M, Perez M, Trono K, Fondevila N (2011) Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus. J Virol Methods 178:191–200CrossRefPubMed
15.
go back to reference Lubroth J, Brown F (1995) Identification of native foot-and-mouth virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res Vet Sci 59:70–78CrossRefPubMed Lubroth J, Brown F (1995) Identification of native foot-and-mouth virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res Vet Sci 59:70–78CrossRefPubMed
16.
go back to reference Biswal JK, Ranjan R, Pattnaik B (2016) Diagnostic application of recombinant non-structural protein 3A to detect antibodies induced by foot-and-mouth disease virus infection. Biologicals 44(3):157–162CrossRefPubMed Biswal JK, Ranjan R, Pattnaik B (2016) Diagnostic application of recombinant non-structural protein 3A to detect antibodies induced by foot-and-mouth disease virus infection. Biologicals 44(3):157–162CrossRefPubMed
18.
go back to reference Studier FW, Moffatt BA (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189:113–130CrossRefPubMed Studier FW, Moffatt BA (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol 189:113–130CrossRefPubMed
19.
go back to reference Jácamo R, López N, Wilda M, Franze-Fernández MT (2003) Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis. J Virol 77:10383–10393CrossRefPubMedPubMedCentral Jácamo R, López N, Wilda M, Franze-Fernández MT (2003) Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis. J Virol 77:10383–10393CrossRefPubMedPubMedCentral
20.
go back to reference Yantsevich AV, Gilep AA, Usanov SA (2009) Conformational stability of cytochrome b5, enhanced green fluorescent protein, and their fusion protein Hmwb5-EGFP. Biochemistry (Mosc) 74(5):518–527CrossRef Yantsevich AV, Gilep AA, Usanov SA (2009) Conformational stability of cytochrome b5, enhanced green fluorescent protein, and their fusion protein Hmwb5-EGFP. Biochemistry (Mosc) 74(5):518–527CrossRef
Metadata
Title
Recombinant foot-and-mouth disease virus (FMDV) non-structural protein 3A fused to enhanced green fluorescent protein (EGFP) as a candidate probe to identify FMDV-infected cattle in serosurveys
Authors
Cecilia M. Lotufo
Ingrid E. Bergmann
Nora M. Mattion
Maximiliano Wilda
Pablo R. Grigera
Publication date
01-08-2017
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 8/2017
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-017-3359-4

Other articles of this Issue 8/2017

Archives of Virology 8/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.